These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients. Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297 [TBL] [Abstract][Full Text] [Related]
5. Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome. Schneider NB; Pastor T; Paula AE; Achatz MI; Santos ÂRD; Vianna FSL; Rosset C; Pinheiro M; Ashton-Prolla P; Moreira MÂM; Palmero EI; Cancer Med; 2018 May; 7(5):2078-2088. PubMed ID: 29575718 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome family. Yang C; Sheehan M; Borras E; Cadoo K; Offit K; Zhang L Fam Cancer; 2020 Oct; 19(4):315-322. PubMed ID: 32356167 [TBL] [Abstract][Full Text] [Related]
7. Functional Characterization of a Missense Variant of Zaib T; Zhang C; Saleem K; Xu L; Qin Q; Wang Y; Ji W; Khan H; Yu H; Zhu S; Gao W; Huang Y; Jia X; Wu J; Song H; Zhang Y; Sun W; Fu S Dis Markers; 2020; 2020():8360841. PubMed ID: 32076465 [TBL] [Abstract][Full Text] [Related]
8. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579 [TBL] [Abstract][Full Text] [Related]
9. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186 [TBL] [Abstract][Full Text] [Related]
10. MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation Status. Kurpiel B; Thomas MS; Mubeen M; Ring KL; Modesitt SC; Moskaluk CA; Mills AM Int J Gynecol Pathol; 2022 Jan; 41(1):1-11. PubMed ID: 33577226 [TBL] [Abstract][Full Text] [Related]
11. A PMS2 non-canonical splicing site variant leads to aberrant splicing in a patient suspected for lynch syndrome. Bouras A; Naibo P; Legrand C; Marc'hadour FL; Ruano E; Grand-Masson C; Lefol C; Wang Q Fam Cancer; 2023 Jul; 22(3):303-306. PubMed ID: 36445599 [TBL] [Abstract][Full Text] [Related]
12. Association of a novel frameshift variant and a known deleterious variant in MMR genes with Lynch syndrome in Chinese families. Li J; Ni H; Wang X; Cheng W; Li L; Cheng Y; Liu C; Li Y; Deng A World J Surg Oncol; 2024 Jan; 22(1):36. PubMed ID: 38280988 [TBL] [Abstract][Full Text] [Related]
13. Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients. Petersen SM; Dandanell M; Rasmussen LJ; Gerdes AM; Krogh LN; Bernstein I; Okkels H; Wikman F; Nielsen FC; Hansen TV BMC Med Genet; 2013 Oct; 14():103. PubMed ID: 24090359 [TBL] [Abstract][Full Text] [Related]
14. Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants. Pagenstecher C; Wehner M; Friedl W; Rahner N; Aretz S; Friedrichs N; Sengteller M; Henn W; Buettner R; Propping P; Mangold E Hum Genet; 2006 Mar; 119(1-2):9-22. PubMed ID: 16341550 [TBL] [Abstract][Full Text] [Related]
15. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of CNV-neutral structural genomic rearrangements in MLH1, MSH2, and PMS2 not detectable in routine NGS diagnostics. Morak M; Steinke-Lange V; Massdorf T; Benet-Pages A; Locher M; Laner A; Kayser K; Aretz S; Holinski-Feder E Fam Cancer; 2020 Apr; 19(2):161-167. PubMed ID: 32002723 [TBL] [Abstract][Full Text] [Related]
17. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome. Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257 [TBL] [Abstract][Full Text] [Related]
18. The spectrum of Lynch syndrome-associated germ-line mutations in Russia. Yanus GA; Akhapkina TA; Iyevleva AG; Kornilov AV; Suspitsin EN; Kuligina ES; Ivantsov AO; Aleksakhina SN; Sokolova TN; Sokolenko AP; Togo AV; Imyanitov EN Eur J Med Genet; 2020 Mar; 63(3):103753. PubMed ID: 31491536 [TBL] [Abstract][Full Text] [Related]
19. A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient. Chen X; Li X; Liang H; Wei L; Cui Q; Yao M; Wu X Mol Genet Genomic Med; 2019 Aug; 7(8):e787. PubMed ID: 31207149 [TBL] [Abstract][Full Text] [Related]
20. Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2. Ten Broeke SW; van Bavel TC; Jansen AML; Gómez-García E; Hes FJ; van Hest LP; Letteboer TGW; Olderode-Berends MJW; Ruano D; Spruijt L; Suerink M; Tops CM; van Eijk R; Morreau H; van Wezel T; Nielsen M Gastroenterology; 2018 Sep; 155(3):844-851. PubMed ID: 29758216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]